Breaking News Instant updates and real-time market news.

TGTX

TG Therapeutics

$28.61 /

-0.88 (-2.98%)

07:32
10/21/20
10/21
07:32
10/21/20
07:32

TG Therapeutics announces Fast Track Designation for ublituximab with umbralisib

TG Therapeutics announced that the U.S. Food and Drug Administration has granted Fast Track Designation to the combination of ublituximab, the Company's investigational glycoengineered anti-CD20 monoclonal antibody, and umbralisib, the Company's investigational once-daily, oral, dual inhibitor of PI3K-delta and CK1-epsilon, for the treatment of adult patients with chronic lymphocytic leukemia.

  • 15

    Feb

  • 15

    Jun

  • 15

    May

TGTX TG Therapeutics
$28.61 /

-0.88 (-2.98%)

10/09/20 B. Riley Securities
TG Therapeutics price target raised to $52 from $37 at B. Riley Securities
10/06/20 Jefferies
TG Therapeutics price target raised to $47 from $23 at Jefferies
09/01/20 JPMorgan
TG Therapeutics initiated with an Overweight at JPMorgan
08/11/20 Cantor Fitzgerald
TG Therapeutics price target lowered to $30 from $35 at Cantor Fitzgerald

TODAY'S FREE FLY STORIES

Downgrade
Wood Group downgraded to Hold from Buy at Kepler Cheuvreux » 05:10
12/02/20
12/02
05:10
12/02/20
05:10
WDGJF

Wood Group

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WDGJF Wood Group
$0.00 /

+ (+0.00%)

11/27/20 RBC Capital
Wood Group price target raised to 360 GBp from 300 GBp at RBC Capital
11/17/20 Morgan Stanley
Wood Group price target raised to 324 GBp from 303 GBp at Morgan Stanley
11/02/20 Goldman Sachs
Wood Group downgraded to Neutral from Buy at Goldman Sachs
10/13/20 Morgan Stanley
Wood Group price target raised to 303 GBp from 275 GBp at Morgan Stanley
Upgrade
Thyssenkrupp upgraded to Hold from Reduce at Kepler Cheuvreux » 05:09
12/02/20
12/02
05:09
12/02/20
05:09
TKAMY

Thyssenkrupp

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TKAMY Thyssenkrupp
$0.00 /

+ (+0.00%)

TKAMY Thyssenkrupp
$0.00 /

+ (+0.00%)

11/25/20 Deutsche Bank
Thyssenkrupp upgraded to Buy from Hold at Deutsche Bank
10/16/20 JPMorgan
Thyssenkrupp price target raised to EUR 5.30 from EUR 5.10 at JPMorgan
10/05/20 Morgan Stanley
Thyssenkrupp upgraded to Equal Weight from Underweight at Morgan Stanley
09/24/20 Morgan Stanley
Thyssenkrupp price target lowered to EUR 5.40 from EUR 5.80 at Morgan Stanley
TKAMY Thyssenkrupp
$0.00 /

+ (+0.00%)

Hot Stocks
iRhythm issues comments on CMS 2021 MPFS Final Rule » 05:09
12/02/20
12/02
05:09
12/02/20
05:09
IRTC

iRhythm

$240.65 /

-3.6 (-1.47%)

iRhythm commented on the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRTC iRhythm
$240.65 /

-3.6 (-1.47%)

IRTC iRhythm
$240.65 /

-3.6 (-1.47%)

11/17/20
Fly Intel: Top five analyst downgrades
11/17/20 Oppenheimer
iRhythm downgraded to Perform on 'crazy multiples' at Oppenheimer
11/17/20 Oppenheimer
iRhythm downgraded to Perform from Outperform at Oppenheimer
11/06/20 Canaccord
iRhythm price target raised to $273 from $236 at Canaccord
IRTC iRhythm
$240.65 /

-3.6 (-1.47%)

  • 19
    Aug
Upgrade
Ryanair upgraded to Add from Sell at AlphaValue » 05:09
12/02/20
12/02
05:09
12/02/20
05:09
RYAAY

Ryanair

$105.90 /

+2.1 (+2.02%)

AlphaValue upgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RYAAY Ryanair
$105.90 /

+2.1 (+2.02%)

RYAAY Ryanair
$105.90 /

+2.1 (+2.02%)

11/30/20 Goldman Sachs
Ryanair price target raised to EUR 18.1 from EUR 14.2 at Goldman Sachs
11/27/20 JPMorgan
Ryanair price target raised to EUR 18.5 from EUR 13 at JPMorgan
11/12/20 UBS
Ryanair downgraded to Neutral from Buy at UBS
11/10/20 Credit Suisse
Ryanair price target raised to EUR 17.23 from EUR 15.16 at Credit Suisse
Downgrade
Hasbro downgraded to Market Perform from Outperform at BMO Capital » 05:08
12/02/20
12/02
05:08
12/02/20
05:08
HAS

Hasbro

$96.14 /

+2.99 (+3.21%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HAS Hasbro
$96.14 /

+2.99 (+3.21%)

HAS Hasbro
$96.14 /

+2.99 (+3.21%)

11/23/20 KeyBanc
Hasbro price target raised to $100 from $92 at KeyBanc
10/27/20 DA Davidson
Hasbro price target raised to $105 from $100 at DA Davidson
10/27/20 Truist
Hasbro price target raised to $82 from $75 at Truist
10/27/20 KeyBanc
Hasbro price target raised to $92 from $85 at KeyBanc
HAS Hasbro
$96.14 /

+2.99 (+3.21%)

HAS Hasbro
$96.14 /

+2.99 (+3.21%)

HAS Hasbro
$96.14 /

+2.99 (+3.21%)

Initiation
Bruker initiated with a Sell at Goldman Sachs » 05:06
12/02/20
12/02
05:06
12/02/20
05:06
BRKR

Bruker

$51.50 /

+0.92 (+1.82%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRKR Bruker
$51.50 /

+0.92 (+1.82%)

BRKR Bruker
$51.50 /

+0.92 (+1.82%)

11/16/20 Wolfe Research
Bruker upgraded to Peer Perform from Underperform at Wolfe Research
08/04/20 Wells Fargo
Bruker price target raised to $52 from $42 at Wells Fargo
08/04/20 SVB Leerink
Bruker price target raised to $50 from $45 at SVB Leerink
05/07/20 Wells Fargo
Bruker price target lowered to $42 from $50 at Wells Fargo
BRKR Bruker
$51.50 /

+0.92 (+1.82%)

  • 21
    Oct
BRKR Bruker
$51.50 /

+0.92 (+1.82%)

Hot Stocks
Trinseo launches new TPE pilot facility in Hsinchu, Taiwan » 05:05
12/02/20
12/02
05:05
12/02/20
05:05
TSE

Trinseo

$38.83 /

+0.79 (+2.08%)

Trinseo announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSE Trinseo
$38.83 /

+0.79 (+2.08%)

TSE Trinseo
$38.83 /

+0.79 (+2.08%)

11/18/20 Morgan Stanley
Trinseo upgraded to Equal Weight from Underweight at Morgan Stanley
11/18/20 Morgan Stanley
Trinseo upgraded to Equal Weight from Underweight at Morgan Stanley
11/10/20 Deutsche Bank
Trinseo price target raised to $40 from $36 at Deutsche Bank
10/20/20 Deutsche Bank
Trinseo price target raised to $36 from $24 at Deutsche Bank
TSE Trinseo
$38.83 /

+0.79 (+2.08%)

TSE Trinseo
$38.83 /

+0.79 (+2.08%)

Initiation
Waters initiated with a Neutral at Goldman Sachs » 05:05
12/02/20
12/02
05:05
12/02/20
05:05
WAT

Waters

$234.15 /

+2.185 (+0.94%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WAT Waters
$234.15 /

+2.185 (+0.94%)

WAT Waters
$234.15 /

+2.185 (+0.94%)

11/09/20 KeyBanc
Waters initiated with a Sector Weight at KeyBanc
10/28/20 Citi
Waters price target raised to $185 from $180 at Citi
07/29/20 SVB Leerink
Waters price target raised to $225 from $195 at SVB Leerink
07/29/20 Citi
Waters price target raised to $180 from $150 at Citi
WAT Waters
$234.15 /

+2.185 (+0.94%)

WAT Waters
$234.15 /

+2.185 (+0.94%)

Initiation
Mettler-Toledo initiated with a Neutral at Goldman Sachs » 05:04
12/02/20
12/02
05:04
12/02/20
05:04
MTD

Mettler-Toledo

$1,162.42 /

+28.87 (+2.55%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTD Mettler-Toledo
$1,162.42 /

+28.87 (+2.55%)

MTD Mettler-Toledo
$1,162.42 /

+28.87 (+2.55%)

10/07/20
Fly Intel: Top five analyst downgrades
10/07/20 UBS
Mettler-Toledo downgraded to Sell from Neutral at UBS
10/07/20 UBS
Mettler-Toledo downgraded to Sell from Neutral at UBS
09/28/20 JPMorgan
JPMorgan downgrades Mettler-Toledo to Underweight on 'meaningful disconnect'
MTD Mettler-Toledo
$1,162.42 /

+28.87 (+2.55%)

Initiation
10x Genomics initiated with a Neutral at Goldman Sachs » 05:03
12/02/20
12/02
05:03
12/02/20
05:03
TXG

10x Genomics

$149.47 /

-3.66 (-2.39%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TXG 10x Genomics
$149.47 /

-3.66 (-2.39%)

TXG 10x Genomics
$149.47 /

-3.66 (-2.39%)

11/11/20 Citi
10x Genomics price target raised to $165 from $120 at Citi
09/15/20 JPMorgan
10x Genomics price target raised to $140 from $110 at JPMorgan
09/09/20 Morgan Stanley
10x Genomics initiated with an Overweight at Morgan Stanley
08/12/20 JPMorgan
10x Genomics price target raised to $110 from $95 at JPMorgan
TXG 10x Genomics
$149.47 /

-3.66 (-2.39%)

  • 11
    Sep
TXG 10x Genomics
$149.47 /

-3.66 (-2.39%)

Initiation
Agilent initiated with a Buy at Goldman Sachs » 05:02
12/02/20
12/02
05:02
12/02/20
05:02
A

Agilent

$115.34 /

-1.56 (-1.33%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
A Agilent
$115.34 /

-1.56 (-1.33%)

A Agilent
$115.34 /

-1.56 (-1.33%)

11/25/20
Fly Intel: Top five analyst upgrades
11/25/20 UBS
Agilent upgraded to Buy from Neutral at UBS
11/24/20 SVB Leerink
Agilent price target raised to $120 from $100 at SVB Leerink
11/24/20 JPMorgan
Agilent price target raised to $125 from $110 at JPMorgan
A Agilent
$115.34 /

-1.56 (-1.33%)

A Agilent
$115.34 /

-1.56 (-1.33%)

A Agilent
$115.34 /

-1.56 (-1.33%)

Initiation
Danaher initiated with a Buy at Goldman Sachs » 05:01
12/02/20
12/02
05:01
12/02/20
05:01
DHR

Danaher

$225.00 /

+0.4 (+0.18%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DHR Danaher
$225.00 /

+0.4 (+0.18%)

DHR Danaher
$225.00 /

+0.4 (+0.18%)

11/25/20 RBC Capital
Danaher downgraded to Sector Perform from Outperform at RBC Capital
11/25/20 RBC Capital
Danaher downgraded to Sector Perform from Outperform at RBC Capital
11/09/20 KeyBanc
Danaher initiated with an Overweight at KeyBanc
10/27/20 Needham
Danaher price target raised to $272 from $209 at Needham
DHR Danaher
$225.00 /

+0.4 (+0.18%)

  • 08
    May
DHR Danaher
$225.00 /

+0.4 (+0.18%)

DHR Danaher
$225.00 /

+0.4 (+0.18%)

Initiation
PerkinElmer initiated with a Buy at Goldman Sachs » 04:59
12/02/20
12/02
04:59
12/02/20
04:59
PKI

PerkinElmer

$137.21 /

+4.24 (+3.19%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PKI PerkinElmer
$137.21 /

+4.24 (+3.19%)

PKI PerkinElmer
$137.21 /

+4.24 (+3.19%)

11/09/20 KeyBanc
PerkinElmer initiated with a Sector Weight at KeyBanc
11/09/20 Needham
PerkinElmer price target raised to $193 from $139 at Needham
10/29/20 Wells Fargo
PerkinElmer price target raised to $140 from $130 at Wells Fargo
10/29/20 Baird
PerkinElmer price target raised to $151 from $137 at Baird
PKI PerkinElmer
$137.21 /

+4.24 (+3.19%)

PKI PerkinElmer
$137.21 /

+4.24 (+3.19%)

PKI PerkinElmer
$137.21 /

+4.24 (+3.19%)

PKI PerkinElmer
$137.21 /

+4.24 (+3.19%)

Initiation
Thermo Fisher initiated with a Buy at Goldman Sachs » 04:58
12/02/20
12/02
04:58
12/02/20
04:58
TMO

Thermo Fisher

$470.99 /

+5.99 (+1.29%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TMO Thermo Fisher
$470.99 /

+5.99 (+1.29%)

TMO Thermo Fisher
$470.99 /

+5.99 (+1.29%)

12/01/20 Cowen
Thermo Fisher Base business, COVID tailwinds driving another beat, says Cowen
11/09/20 KeyBanc
Thermo Fisher initiated with a Sector Weight at KeyBanc
10/27/20 Needham
Thermo Fisher price target raised to $539 from $477 at Needham
10/22/20 SVB Leerink
Thermo Fisher price target raised to $525 from $470 at SVB Leerink
TMO Thermo Fisher
$470.99 /

+5.99 (+1.29%)

TMO Thermo Fisher
$470.99 /

+5.99 (+1.29%)

TMO Thermo Fisher
$470.99 /

+5.99 (+1.29%)

TMO Thermo Fisher
$470.99 /

+5.99 (+1.29%)

Upgrade
Kirin upgraded to Conviction Buy from Neutral at Goldman Sachs » 04:55
12/02/20
12/02
04:55
12/02/20
04:55
KNBWY

Kirin

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KNBWY Kirin
$0.00 /

+ (+0.00%)

Conference/Events
Morgan Stanley sustainability analysts hold analyst/industry conference call » 04:55
12/02/20
12/02
04:55
12/02/20
04:55

Global Head of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Atlas Technical Consultants management to meet virtually with Lake Street » 04:55
12/02/20
12/02
04:55
12/02/20
04:55
ATCX

Atlas Technical Consultants

$5.49 /

+0.33 (+6.40%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
ATCX Atlas Technical Consultants
$5.49 /

+0.33 (+6.40%)

ATCX Atlas Technical Consultants
$5.49 /

+0.33 (+6.40%)

08/11/20 DA Davidson
Atlas Technical Consultants upgraded to Buy from Neutral at DA Davidson
08/11/20 DA Davidson
Atlas Technical Consultants upgraded to Buy from Neutral at DA Davidson
07/01/20 DA Davidson
Atlas Technical Consultants initiated with a Neutral at DA Davidson
04/08/20
Atlas Technical Consultants participates in a conference call with Lake Street
ATCX Atlas Technical Consultants
$5.49 /

+0.33 (+6.40%)

  • 14
    Aug
Conference/Events
Radiant Logistics management to meet virtually with Loop Capital » 04:55
12/02/20
12/02
04:55
12/02/20
04:55
RLGT

Radiant Logistics

$5.99 /

+0.05 (+0.84%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RLGT Radiant Logistics
$5.99 /

+0.05 (+0.84%)

RLGT Radiant Logistics
$5.99 /

+0.05 (+0.84%)

05/12/20 Lake Street
Radiant Logistics price target lowered to $7 from $9 at Lake Street
02/28/20 Benchmark
Radiant Logistics initiated with a Buy at Benchmark
RLGT Radiant Logistics
$5.99 /

+0.05 (+0.84%)

RLGT Radiant Logistics
$5.99 /

+0.05 (+0.84%)

Conference/Events
Investors Real Estate management to meet virtually with BTIG » 04:55
12/02/20
12/02
04:55
12/02/20
04:55
IRET

Investors Real Estate

$70.39 /

+1.09 (+1.57%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRET Investors Real Estate
$70.39 /

+1.09 (+1.57%)

IRET Investors Real Estate
$70.39 /

+1.09 (+1.57%)

09/24/20 DA Davidson
Investors Real Estate price target lowered to $70 from $75 at DA Davidson
08/20/20
Fly Intel: Top five analyst downgrades
08/20/20 Raymond James
Investors Real Estate downgraded on pricing concerns at Raymond James
08/20/20 Raymond James
Investors Real Estate downgraded to Market Perform at Raymond James
IRET Investors Real Estate
$70.39 /

+1.09 (+1.57%)

General news
Federal Reserve Bank of New York President John Williams Speech to be released at 13:00  04:55
12/02/20
12/02
04:55
12/02/20
04:55
 
General news
Week of 11/27 MBA Mortgage Applications to be released at 07:00  04:55
12/02/20
12/02
04:55
12/02/20
04:55
 
General news
Federal Reserve Chairman Jerome Powell Speech to be released at 10:00  04:55
12/02/20
12/02
04:55
12/02/20
04:55
 
Conference/Events
Jefferies to hold a virtual summit » 04:55
12/02/20
12/02
04:55
12/02/20
04:55
SUMO

Sumo Logic

$25.09 /

-1.05 (-4.02%)

Virtual Public Cloud…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
SUMO Sumo Logic
$25.09 /

-1.05 (-4.02%)

SUMO Sumo Logic
$25.09 /

-1.05 (-4.02%)

11/17/20 Berenberg
Sumo Logic initiated with a Buy at Berenberg
10/12/20 William Blair
Sumo Logic initiated with an Outperform at William Blair
10/12/20 JPMorgan
Sumo Logic initiated with a Neutral at JPMorgan
10/12/20 Morgan Stanley
Sumo Logic initiated with an Equal Weight at Morgan Stanley
  • 17
    Sep
SUMO Sumo Logic
$25.09 /

-1.05 (-4.02%)

Conference/Events
Piper Sandler to hold a virtual conference » 04:55
12/02/20
12/02
04:55
12/02/20
04:55
ABMD

Abiomed

$268.45 /

-5.95 (-2.17%)

, VCRA

Vocera

$34.64 /

+0.87 (+2.58%)

, ICPT

Intercept

$35.69 /

+0.21 (+0.59%)

, IMV

IMV Inc.

$3.63 /

-0.23 (-5.96%)

, OTIC

Otonomy

$4.81 /

+0.345 (+7.73%)

, OMCL

Omnicell

$107.17 /

+2.4 (+2.29%)

, NRIX

Nurix Therapeutics

$42.93 /

+0.31 (+0.73%)

, FULC

Fulcrum Therapeutics

$12.00 /

+0.56 (+4.90%)

, NCNA

NuCana

$4.52 /

+0.02 (+0.44%)

, XNCR

Xencor

$41.36 /

-0.97 (-2.29%)

, ZBH

Zimmer Biomet

$146.00 /

-3.175 (-2.13%)

, MASI

Masimo

$253.27 /

-1.38 (-0.54%)

, ALBO

Albireo Pharma

$37.93 /

+0.72 (+1.93%)

, ALGN

Align Technology

$500.52 /

+18.81 (+3.90%)

, ALLO

Allogene Therapeutics

$31.91 /

+0.9 (+2.90%)

, ALPN

Alpine Immune Sciences

$9.64 /

-0.305 (-3.07%)

, ALT

Altimmune

$13.82 /

+1.63 (+13.37%)

, AMRN

Amarin

$4.92 /

-0.04 (-0.81%)

, APTX

Aptinyx

$3.55 /

-0.425 (-10.71%)

, BBI

Brickell Biotech

$0.64 /

-0.0289 (-4.31%)

, MDT

Medtronic

$112.24 /

-1.49 (-1.31%)

32nd Annual Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
ABMD Abiomed
$268.45 /

-5.95 (-2.17%)

VCRA Vocera
$34.64 /

+0.87 (+2.58%)

ICPT Intercept
$35.69 /

+0.21 (+0.59%)

IMV IMV Inc.
$3.63 /

-0.23 (-5.96%)

OTIC Otonomy
$4.81 /

+0.345 (+7.73%)

OMCL Omnicell
$107.17 /

+2.4 (+2.29%)

NRIX Nurix Therapeutics
$42.93 /

+0.31 (+0.73%)

FULC Fulcrum Therapeutics
$12.00 /

+0.56 (+4.90%)

NCNA NuCana
$4.52 /

+0.02 (+0.44%)

XNCR Xencor
$41.36 /

-0.97 (-2.29%)

ZBH Zimmer Biomet
$146.00 /

-3.175 (-2.13%)

MASI Masimo
$253.27 /

-1.38 (-0.54%)

ALBO Albireo Pharma
$37.93 /

+0.72 (+1.93%)

ALGN Align Technology
$500.52 /

+18.81 (+3.90%)

ALLO Allogene Therapeutics
$31.91 /

+0.9 (+2.90%)

ALPN Alpine Immune Sciences
$9.64 /

-0.305 (-3.07%)

ALT Altimmune
$13.82 /

+1.63 (+13.37%)

AMRN Amarin
$4.92 /

-0.04 (-0.81%)

APTX Aptinyx
$3.55 /

-0.425 (-10.71%)

BBI Brickell Biotech
$0.64 /

-0.0289 (-4.31%)

MDT Medtronic
$112.24 /

-1.49 (-1.31%)

ABMD Abiomed
$268.45 /

-5.95 (-2.17%)

10/20/20 Piper Sandler
Abiomed's TCT presentation highlights solid existing data, says Piper Sandler
08/07/20 SVB Leerink
Abiomed price target raised to $335 from $280 at SVB Leerink
07/13/20 OTR Global
Abiomed upgraded to Positive from Mixed at OTR Global
05/28/20 SVB Leerink
Abiomed price target raised to $225 from $195 at SVB Leerink
VCRA Vocera
$34.64 /

+0.87 (+2.58%)

11/10/20 Stephens
Vocera initiated with an Overweight at Stephens
10/30/20 Piper Sandler
Vocera price target raised to $41 from $28 at Piper Sandler
07/28/20
Fly Intel: Top five analyst upgrades
07/28/20 Craig-Hallum
Vocera upgraded to Buy from Hold at Craig-Hallum
ICPT Intercept
$35.69 /

+0.21 (+0.59%)

11/30/20 Citi
Intercept risk/reward favorable after pullback, says Citi
11/30/20 Citi
CymaBay price target raised to $10 from $9 at Citi
11/20/20 B. Riley Securities
Intercept price target lowered to $74 from $97 at B. Riley Securities
11/16/20 RBC Capital
RBC says new AE data on Ocaliva's Intercept 'does not reassure'
IMV IMV Inc.
$3.63 /

-0.23 (-5.96%)

07/21/20 Industrial Alliance
IMV Inc. initiated with a Buy at Industrial Alliance
07/14/20 Wells Fargo
IMV Inc. price target raised to $11 from $8.50 at Wells Fargo
05/18/20 Wells Fargo
IMV Inc. upgraded to Overweight on COVID-19 vaccine potential at Wells Fargo
05/18/20 Wells Fargo
IMV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
OTIC Otonomy
$4.81 /

+0.345 (+7.73%)

11/04/20 Piper Sandler
Piper Sandler likes risk/reward on Otonomy ahead of two readouts by year-end
07/07/20 Cantor Fitzgerald
Otonomy price target raised to $11 from $9 at Cantor Fitzgerald
07/07/20 H.C. Wainwright
Otonomy price target raised to $9 from $8 at H.C. Wainwright
06/15/20 Piper Sandler
Piper remains optimistic on Otonomy ahead of near-term clinical readouts
OMCL Omnicell
$107.17 /

+2.4 (+2.29%)

10/28/20 Craig-Hallum
Omnicell price target raised to $100 from $85 at Craig-Hallum
10/28/20 Wells Fargo
Omnicell price target raised to $84 from $74 at Wells Fargo
10/28/20 Cantor Fitzgerald
Omnicell price target raised to $95 from $90 at Cantor Fitzgerald
10/28/20 Piper Sandler
Omnicell price target raised to $86 from $70 at Piper Sandler
NRIX Nurix Therapeutics
$42.93 /

+0.31 (+0.73%)

11/24/20 Morgan Stanley
Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley
11/19/20 Baird
Baird starts Nurix Therapeutics with Outperform, $40 price target
11/18/20 Baird
Nurix Therapeutics initiated with an Outperform at Baird
08/18/20
Fly Intel: Top five analyst initiations
FULC Fulcrum Therapeutics
$12.00 /

+0.56 (+4.90%)

10/15/20 Piper Sandler
Fulcrum Therapeutics initiated with an Overweight at Piper Sandler
08/12/20
Fly Intel: Top five analyst downgrades
08/12/20 BTIG
Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG
08/12/20 Morgan Stanley
Fulcrum Therapeutics downgraded at Morgan Stanley, price target slashed to $11
NCNA NuCana
$4.52 /

+0.02 (+0.44%)

12/01/20 H.C. Wainwright
NuCana price target lowered to $10 from $15 at H.C. Wainwright
11/24/20 H.C. Wainwright
NuCana price target lowered to $15 from $17 at H.C. Wainwright
10/22/20 Truist
NuCana initiated with a Buy at Truist
10/22/20 Truist
NuCana initiated with a Buy at Truist
XNCR Xencor
$41.36 /

-0.97 (-2.29%)

11/16/20 Cantor Fitzgerald
Xencor price target raised to $56 from $40 at Cantor Fitzgerald
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
07/08/20 Piper Sandler
Xencor, Atreca deal offers synergies for XmAb design, says Piper Sandler
06/22/20 Piper Sandler
Xencor's '2+1' biospecific antibodies ideal for solid tumors, says Piper Sandler
ZBH Zimmer Biomet
$146.00 /

-3.175 (-2.13%)

11/09/20 SVB Leerink
Zimmer Biomet price target raised to $167 from $160 at SVB Leerink
11/09/20 Credit Suisse
Zimmer Biomet price target raised to $106 from $99 at Credit Suisse
11/09/20 Baird
Zimmer Biomet valuation discount to peers hard to justify, says at Baird
11/09/20 Oppenheimer
Zimmer Biomet price target raised to $155 from $150 at Oppenheimer
MASI Masimo
$253.27 /

-1.38 (-0.54%)

11/02/20 Piper Sandler
Masimo acquisition brings 'solid opportunity,' says Piper Sandler
10/28/20 Piper Sandler
Masimo price target raised to $280 from $250 at Piper Sandler
10/06/20 Piper Sandler
Better than expected sensor utilization drove Masimo upside, says Piper Sandler
09/01/20 Baird
Masimo initiated with an Outperform at Baird
ALBO Albireo Pharma
$37.93 /

+0.72 (+1.93%)

09/10/20 Cowen
Albireo Pharma price target raised to $65 from $39 at Cowen
09/09/20 Guggenheim
Mirum Pharmaceuticals price target raised to $38 from $27 at Guggenheim
09/08/20 William Blair
William Blair says Albireo data confirms 'best-in-class' profile for odevixibat
09/08/20 Jefferies
Albireo Pharma price target raised to $79 from $50 at Jefferies
ALGN Align Technology
$500.52 /

+18.81 (+3.90%)

11/24/20 SVB Leerink
Align Technology price target raised to $520 from $460 at SVB Leerink
11/24/20 Credit Suisse
Align Technology price target raised to $515 from $432 at Credit Suisse
11/24/20 Goldman Sachs
Align Technology price target raised to $535 from $472 at Goldman Sachs
11/24/20 Baird
Align Technology price target raised to $530 from $450 at Baird
ALLO Allogene Therapeutics
$31.91 /

+0.9 (+2.90%)

11/24/20 BofA
Allogene Therapeutics initiated with a Buy at BofA
11/24/20 BofA
Allogene Therapeutics initiated with a Buy at BofA
11/04/20 Oppenheimer
Allogene weakness after abstract a buying opportunity, says Oppenheimer
11/04/20 Roth Capital
Question of safety with Allogene's Allo-CARs may be premature, says Roth Capital
ALPN Alpine Immune Sciences
$9.64 /

-0.305 (-3.07%)

08/26/20 Cowen
Alpine Immune Sciences initiated with an Outperform at Cowen
08/11/20 Piper Sandler
Alpine Immune Sciences price target lowered to $18 from $21 at Piper Sandler
06/19/20 Wedbush
Alpine Immune price target raised to $22 from $10 at Wedbush
06/18/20 Piper Sandler
Alpine Immune Sciences price target raised to $21 from $8 at Piper Sandler
ALT Altimmune
$13.82 /

+1.63 (+13.37%)

11/25/20 Piper Sandler
Phase 1 safety/immunogenicity to set Altimmune AdCOVID apart, says Piper Sandler
11/24/20 Piper Sandler
Astra vaccine results 'de-risking' for Altimmune, says Piper Sandler
11/12/20 B. Riley Securities
Altimmune selloff on vaccine news overblown, says B. Riley Securities
10/12/20 Piper Sandler
Piper sees AdCOVID pre-clinical data helping benchmark Altimmune COVID program
AMRN Amarin
$4.92 /

-0.04 (-0.81%)

12/01/20 Goldman Sachs
Amarin faces 'generally high bar' in suit against Hikma, says Goldman Sachs
11/20/20 Piper Sandler
Piper keeps $19 target on Amarin, sees China as potential 'lucrative' market
11/05/20 Piper Sandler
Piper remains bullish about Vascepa after Amarin Q3 report, Hikma announcement
10/26/20 Piper Sandler
Piper says Amarin presentations add 'layers of compelling evidence' for Vascepa
APTX Aptinyx
$3.55 /

-0.425 (-10.71%)

11/19/20 H.C. Wainwright
Aptinyx price target raised to $8 from $7 at H.C. Wainwright
11/12/20 Piper Sandler
Aptinyx pipeline catalysts on track, says Piper Sandler
10/28/20 Cantor Fitzgerald
Aptinyx price target raised to $12 from $9 at Cantor Fitzgerald
10/27/20 Piper Sandler
Aptinyx initiated with an Overweight at Piper Sandler
BBI Brickell Biotech
$0.64 /

-0.0289 (-4.31%)

09/25/20 Lake Street
Approval in Japan validating for Brickell Biotech, says Lake Street
08/28/20 Lake Street
Brickell Biotech initiated with a Buy at Lake Street
08/25/20 Oppenheimer
Brickell Biotech initiated with an Outperform at Oppenheimer
MDT Medtronic
$112.24 /

-1.49 (-1.31%)

11/25/20 SVB Leerink
Medtronic price target raised to $123 from $111 at SVB Leerink
11/25/20 Wells Fargo
Medtronic price target raised to $135 from $127 at Wells Fargo
11/25/20 Credit Suisse
Medtronic price target raised to $126 from $118 at Credit Suisse
11/25/20 Oppenheimer
Medtronic price target raised to $128 from $122 at Oppenheimer
ABMD Abiomed
$268.45 /

-5.95 (-2.17%)

VCRA Vocera
$34.64 /

+0.87 (+2.58%)

ICPT Intercept
$35.69 /

+0.21 (+0.59%)

OTIC Otonomy
$4.81 /

+0.345 (+7.73%)

OMCL Omnicell
$107.17 /

+2.4 (+2.29%)

NRIX Nurix Therapeutics
$42.93 /

+0.31 (+0.73%)

FULC Fulcrum Therapeutics
$12.00 /

+0.56 (+4.90%)

NCNA NuCana
$4.52 /

+0.02 (+0.44%)

XNCR Xencor
$41.36 /

-0.97 (-2.29%)

ZBH Zimmer Biomet
$146.00 /

-3.175 (-2.13%)

MASI Masimo
$253.27 /

-1.38 (-0.54%)

ALBO Albireo Pharma
$37.93 /

+0.72 (+1.93%)

ALGN Align Technology
$500.52 /

+18.81 (+3.90%)

ALLO Allogene Therapeutics
$31.91 /

+0.9 (+2.90%)

ALPN Alpine Immune Sciences
$9.64 /

-0.305 (-3.07%)

AMRN Amarin
$4.92 /

-0.04 (-0.81%)

APTX Aptinyx
$3.55 /

-0.425 (-10.71%)

MDT Medtronic
$112.24 /

-1.49 (-1.31%)

  • 23
    Oct
  • 22
    Oct
  • 17
    Sep
  • 10
    Sep
  • 18
    Aug
  • 24
    Jul
  • 14
    Jul
  • 09
    Jul
  • 18
    Jun
  • 02
    Jun
  • 30
    Jan
  • 10
    Jan
ICPT Intercept
$35.69 /

+0.21 (+0.59%)

AMRN Amarin
$4.92 /

-0.04 (-0.81%)

MDT Medtronic
$112.24 /

-1.49 (-1.31%)

VCRA Vocera
$34.64 /

+0.87 (+2.58%)

ICPT Intercept
$35.69 /

+0.21 (+0.59%)

OTIC Otonomy
$4.81 /

+0.345 (+7.73%)

FULC Fulcrum Therapeutics
$12.00 /

+0.56 (+4.90%)

NCNA NuCana
$4.52 /

+0.02 (+0.44%)

MASI Masimo
$253.27 /

-1.38 (-0.54%)

ALBO Albireo Pharma
$37.93 /

+0.72 (+1.93%)

ALGN Align Technology
$500.52 /

+18.81 (+3.90%)

ALT Altimmune
$13.82 /

+1.63 (+13.37%)

AMRN Amarin
$4.92 /

-0.04 (-0.81%)

APTX Aptinyx
$3.55 /

-0.425 (-10.71%)

MDT Medtronic
$112.24 /

-1.49 (-1.31%)

IMV IMV Inc.
$3.63 /

-0.23 (-5.96%)

ALGN Align Technology
$500.52 /

+18.81 (+3.90%)

ALT Altimmune
$13.82 /

+1.63 (+13.37%)

AMRN Amarin
$4.92 /

-0.04 (-0.81%)

APTX Aptinyx
$3.55 /

-0.425 (-10.71%)

MDT Medtronic
$112.24 /

-1.49 (-1.31%)

Conference/Events
EVO Payments management to meet virtually with Truist » 04:55
12/02/20
12/02
04:55
12/02/20
04:55
EVOP

EVO Payments

$25.30 /

+0.08 (+0.32%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 6 minutes

Get Free Trial

ShowHide Related Items >><<
EVOP EVO Payments
$25.30 /

+0.08 (+0.32%)

08/17/20 JPMorgan
EVO Payments price target raised to $33 from $27 at JPMorgan
07/14/20 Goldman Sachs
EVO Payments initiated with a Neutral at Goldman Sachs
06/05/20 Compass Point
EVO Payments price target raised to $22 from $16 at Compass Point
05/11/20 SunTrust
EVO Payments price target raised to $26 from $17 at SunTrust
EVOP EVO Payments
$25.30 /

+0.08 (+0.32%)

  • 25
    Nov
  • 05
    Dec
EVOP EVO Payments
$25.30 /

+0.08 (+0.32%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.